InsidersTradesSigma
Discover the full record of transactions filed by Taveras Arthur, Directeur scientifique. Insider active across 1 companies, notably X4 Pharmaceuticals, Inc. In total, 2 reports have been published. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Arthur Taveras is the Chief Scientific Officer at X4 Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts, focusing on innovation in medical treatments. Arthur Taveras plays a crucial role in advancing scientific projects and collaborating with external partners to enhance clinical outcomes.